Kandice J Varcin1, Charles A Nelson. 1. aLaboratories of Cognitive Neuroscience, Division of Developmental Medicine, Boston Children's Hospital, Harvard Medical School, Boston,bGraduate School of Education, Harvard University, Cambridge Massachusetts USA.
Abstract
PURPOSE OF REVIEW: The delineation of biomarkers in autism spectrum disorder (ASD) offers a promising approach to inform precision-medicine-based approaches to ASD diagnosis and treatment and to move toward a mechanistic description of the disorder. However, biomarkers with sufficient sensitivity or specificity for clinical application in ASD are yet to be realized. Here, we review recent evidence for early, low-level alterations in brain and behavior development that may offer promising avenues for biomarker development in ASD. RECENT FINDINGS: Accumulating evidence suggests that signs associated with ASD may unfold in a manner that maps onto the hierarchical organization of brain development. Genetic and neuroimaging evidence points towards perturbations in brain development early in life, and emerging evidence indicates that sensorimotor development may be among the earliest emerging signs associated with ASD, preceding social and cognitive impairment. SUMMARY: The search for biomarkers of risk, prediction and stratification in ASD may be advanced through a developmental neuroscience approach that looks outside of the core signs of ASD and considers the bottom-up nature of brain development alongside the dynamic nature of development over time. We provide examples of assays that could be incorporated in studies to target low-level circuits.
PURPOSE OF REVIEW: The delineation of biomarkers in autism spectrum disorder (ASD) offers a promising approach to inform precision-medicine-based approaches to ASD diagnosis and treatment and to move toward a mechanistic description of the disorder. However, biomarkers with sufficient sensitivity or specificity for clinical application in ASD are yet to be realized. Here, we review recent evidence for early, low-level alterations in brain and behavior development that may offer promising avenues for biomarker development in ASD. RECENT FINDINGS: Accumulating evidence suggests that signs associated with ASD may unfold in a manner that maps onto the hierarchical organization of brain development. Genetic and neuroimaging evidence points towards perturbations in brain development early in life, and emerging evidence indicates that sensorimotor development may be among the earliest emerging signs associated with ASD, preceding social and cognitive impairment. SUMMARY: The search for biomarkers of risk, prediction and stratification in ASD may be advanced through a developmental neuroscience approach that looks outside of the core signs of ASD and considers the bottom-up nature of brain development alongside the dynamic nature of development over time. We provide examples of assays that could be incorporated in studies to target low-level circuits.
Authors: Jocelyn J LeBlanc; Geneva DeGregorio; Eleonora Centofante; Vanessa K Vogel-Farley; Katherine Barnes; Walter E Kaufmann; Michela Fagiolini; Charles A Nelson Journal: Ann Neurol Date: 2015-09-18 Impact factor: 10.422
Authors: Natalie H Brito; Amy J Elliott; Joseph R Isler; Cynthia Rodriguez; Christa Friedrich; Lauren C Shuffrey; William P Fifer Journal: Dev Psychobiol Date: 2019-06-11 Impact factor: 3.038
Authors: I Kamp-Becker; K Albertowski; J Becker; M Ghahreman; A Langmann; T Mingebach; L Poustka; L Weber; H Schmidt; J Smidt; T Stehr; V Roessner; K Kucharczyk; N Wolff; S Stroth Journal: Eur Child Adolesc Psychiatry Date: 2018-03-20 Impact factor: 4.785
Authors: Laurel J Gabard-Durnam; Carol Wilkinson; Kush Kapur; Helen Tager-Flusberg; April R Levin; Charles A Nelson Journal: Nat Commun Date: 2019-09-13 Impact factor: 14.919
Authors: Alessandra M Pereira; Brunno M Campos; Ana C Coan; Luiz F Pegoraro; Thiago J R de Rezende; Ignacio Obeso; Paulo Dalgalarrondo; Jaderson C da Costa; Jean-Claude Dreher; Fernando Cendes Journal: Front Neurol Date: 2018-07-10 Impact factor: 4.003